Recent Acquisitions Otsuka Pharmaceutical Companies (U.S.) has been actively acquiring companies like Mindset Consulting, LLC and Bonafide Health, LLC. These acquisitions showcase the company's interest in expanding its product offerings and entering new markets, presenting potential sales opportunities for cross-selling and upselling.
Strategic Partnerships Through partnerships such as the one with iBio, Inc. for early-stage PD-1 agonist antibodies and with Verily for a Mental Health registry, Otsuka Us is demonstrating a commitment to innovation. Leveraging these collaborations can open doors for sales representatives to introduce cutting-edge solutions to clients in the pharmaceutical industry.
Recognition and Awards Being recognized with awards like the 2023 Nakahara Memorial Award signifies Otsuka Us's credibility and industry leadership. Sales professionals can leverage this reputation to build trust with potential clients, showcasing the company's excellence and fostering long-term partnerships.
Employee Movement Notable movements in key personnel, such as the departure of Fujita as VP of business planning, are indicators of organizational shifts and potentially new strategic directions. Sales development representatives can use these insights to tailor pitches and offerings according to the company's evolving focus and needs.
Expansion into New Markets Otsuka Us's acquisitions and partnerships are driving expansion into areas like cardio-metabolic space and women's health food products. This diversification presents sales professionals with opportunities to tap into emerging markets and offer tailored solutions to meet evolving customer demands.
15K
$1B
87K$1B
36K$1B
73K$1B
54K$1B
102K$1B
103K$1B
46K$1B
78K$1B
93K$1BOtsuka Pharmaceutical Companies (U.S.) uses 8 technology products and services including MATLAB, Adobe Analytics, Varnish, and more. Explore Otsuka Pharmaceutical Companies (U.S.)'s tech stack below.
| Otsuka Pharmaceutical Companies (U.S.) Email Formats | Percentage |
| First.Last@otsuka-us.com | 79% |
| FirstL@otsuka-us.com | 19% |
| First.Middle@otsuka-us.com | 1% |
| Last.First@otsuka-us.com | 1% |
| First.Last@otsuka.com | 63% |
| FirstL@otsuka.com | 29% |
| Last@otsuka.com | 5% |
| FLast@otsuka.com | 1% |
| FirstLast@otsuka.com | 1% |
| Last.First@otsuka.com | 1% |
Pharmaceutical ManufacturingNew Jersey, United States1001-5000 Employees
There are two Otsuka pharmaceutical industry companies in the U.S.: Otsuka America Pharmaceutical, Inc. (OAPI) successfully commercializes Otsuka-discovered and in-licensed products in North America. Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC) clinically develops and registers innovative healthcare products on a global basis.
Company Overview
Funding & FinancialsOtsuka Pharmaceutical Companies (U.S.)'s revenue is in the range of $100M$1B
Funding & FinancialsOtsuka Pharmaceutical Companies (U.S.)'s revenue is in the range of $100M$1B
1-888-653-2347 
support@leadiq.com